Hide metadata

dc.date.accessioned2019-02-07T13:37:27Z
dc.date.available2019-02-07T13:37:27Z
dc.date.created2018-11-10T13:28:42Z
dc.date.issued2018
dc.identifier.citationPetrelli, Francesco Dallérac, Glenn Pucci, Luca Calì, Corrado Zehnder, Tamara Sultan, Sébastien Lecca, Salvatore Chicca, Andrea Ivanov, Andrei Asensio, Cédric S. Gundersen, Vidar Toni, Nicolas Knott, Graham William Magara, Fulvio Gertsch, Jürg Kirchhoff, Frank Déglon, Nicole Giros, Bruno Edwards, Robert H. Mothet, Jean-Pierre Bezzi, Paola . Dysfunction of homeostatic control of dopamine by astrocytes in the developing prefrontal cortex leads to cognitive impairments. Molecular Psychiatry. 2018, 1-18
dc.identifier.urihttp://hdl.handle.net/10852/66429
dc.description.abstractAstrocytes orchestrate neural development by powerfully coordinating synapse formation and function and, as such, may be critically involved in the pathogenesis of neurodevelopmental abnormalities and cognitive deficits commonly observed in psychiatric disorders. Here, we report the identification of a subset of cortical astrocytes that are competent for regulating dopamine (DA) homeostasis during postnatal development of the prefrontal cortex (PFC), allowing for optimal DA-mediated maturation of excitatory circuits. Such control of DA homeostasis occurs through the coordinated activity of astroglial vesicular monoamine transporter 2 (VMAT2) together with organic cation transporter 3 and monoamine oxidase type B, two key proteins for DA uptake and metabolism. Conditional deletion of VMAT2 in astrocytes postnatally produces loss of PFC DA homeostasis, leading to defective synaptic transmission and plasticity as well as impaired executive functions. Our findings show a novel role for PFC astrocytes in the DA modulation of cognitive performances with relevance to psychiatric disorders.en_US
dc.languageEN
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleDysfunction of homeostatic control of dopamine by astrocytes in the developing prefrontal cortex leads to cognitive impairmentsen_US
dc.typeJournal articleen_US
dc.creator.authorPetrelli, Francesco
dc.creator.authorDallérac, Glenn
dc.creator.authorPucci, Luca
dc.creator.authorCalì, Corrado
dc.creator.authorZehnder, Tamara
dc.creator.authorSultan, Sébastien
dc.creator.authorLecca, Salvatore
dc.creator.authorChicca, Andrea
dc.creator.authorIvanov, Andrei
dc.creator.authorAsensio, Cédric S.
dc.creator.authorGundersen, Vidar
dc.creator.authorToni, Nicolas
dc.creator.authorKnott, Graham William
dc.creator.authorMagara, Fulvio
dc.creator.authorGertsch, Jürg
dc.creator.authorKirchhoff, Frank
dc.creator.authorDéglon, Nicole
dc.creator.authorGiros, Bruno
dc.creator.authorEdwards, Robert H.
dc.creator.authorMothet, Jean-Pierre
dc.creator.authorBezzi, Paola
cristin.unitcode185,53,42,13
cristin.unitnameNevrologisk avdeling
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2
dc.identifier.cristin1628943
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Molecular Psychiatry&rft.volume=&rft.spage=1&rft.date=2018
dc.identifier.jtitleMolecular Psychiatry
dc.identifier.startpage1
dc.identifier.endpage18
dc.identifier.doihttp://dx.doi.org/10.1038/s41380-018-0226-y
dc.identifier.urnURN:NBN:no-69632
dc.type.documentTidsskriftartikkelen_US
dc.type.peerreviewedPeer reviewed
dc.source.issn1359-4184
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/66429/2/Dysfunction%2Bof%2Bhomeostatic%2Bcontrol.pdf
dc.type.versionPublishedVersion


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International